Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

638
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
638
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

998
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
998
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

38.6K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
38.6K
Neural Regulation01:37

Neural Regulation

44.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.6K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

1.7K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.7K
Major Somatic Sensory Pathways01:28

Major Somatic Sensory Pathways

3.3K
Sensory impulses related to touch, pressure, vibration, and proprioception from various body parts, such as the limbs, trunk, neck, and posterior head, travel to the cerebral cortex through the posterior column-medial lemniscus pathway. The pathway’s name derives from the two white-matter tracts that convey the impulses: the spinal cord's posterior column and the brainstem's medial lemniscus. First-order sensory neurons extend their axons into the spinal cord, forming the...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GPIHBP1 as a Biomarker of Diabetic Polyneuropathy and Vascular Complications in Type 2 Diabetes Mellitus.

Biomolecules·2026
Same author

Angiopoietin-like Proteins 4 and 8 in Diabetic Complications: Associations with Neuropathy and Metabolic Parameters in Type 2 Diabetes.

Journal of clinical medicine·2026
Same author

Corneal Confocal Microscopy as a Non-Invasive Marker of Small Fiber Neuropathy and Systemic Complications in Type 2 Diabetes: A Cross-Sectional Study.

Biomolecules·2026
Same author

Growth Differentiation Factor-15 as a Biomarker of Diabetic Complications in Patients with Type 2 Diabetes.

Journal of clinical medicine·2026
Same author

Circulating Neopterin Is Independently Associated with Autonomic Neuropathy in Type 2 Diabetes, but Not with Other Microvascular Complications.

Medical sciences (Basel, Switzerland)·2026
Same author

Distinct Gut Microbiome Profiles Underlying Cardiometabolic Risk Phenotypes in Individuals with Obesity.

Nutrients·2026

Related Experiment Video

Updated: Mar 24, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.8K

Berardinelli-Seip syndrome.

Savelia Gavrailova Yordanova1, Zdravka Todorova2,3, Antoaneta Gateva4

  • 1Department of Internal Diseases, Medical University, Sofia, Bulgaria. savi_gandeva@abv.bg.

Endokrynologia Polska
|March 17, 2026
PubMed
Summary

Berardinelli-Seip syndrome (CGL) is a rare genetic disorder causing severe metabolic issues. Early diagnosis and genetic confirmation are key for managing complications and improving patient outcomes.

Keywords:
AGPAT2 geneBSCLBerardinelli–Seip syndromeCGLcongenital generalized lipodystrophydiabetes mellitushypertriglyceridemia

More Related Videos

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

10.2K
Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
11:05

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model

Published on: October 20, 2023

5.9K

Related Experiment Videos

Last Updated: Mar 24, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.8K
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

10.2K
Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
11:05

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model

Published on: October 20, 2023

5.9K

Area of Science:

  • Genetics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Berardinelli-Seip syndrome (congenital generalized lipodystrophy, CGL) is a rare genetic disorder.
  • Characterized by lipoatrophy, acromegaloid features, hyperinsulinemia, hypertriglyceridemia, and hepatic steatosis.
  • Associated with severe metabolic and cardiovascular complications, impacting morbidity and life expectancy.

Purpose of the Study:

  • To highlight the importance of early diagnosis and genetic confirmation in CGL.
  • To discuss the clinical variability, genetic findings, and therapeutic strategies for CGL.
  • To emphasize comprehensive care and emerging therapies for CGL patients.

Main Methods:

  • Review of molecular genetics identifying mutations in AGPAT2, BSCL2, CAV1, and PTRF.
  • Presentation of two illustrative cases of CGL.
  • Analysis of clinical variability, genetic findings, and therapeutic interventions.

Main Results:

  • Advances in molecular genetics provide insights into adipose tissue biology and metabolism.
  • Identified mutations in specific genes linked to CGL.
  • Demonstrated clinical variability and effectiveness of various therapeutic strategies.

Conclusions:

  • Early recognition and genetic confirmation are crucial for timely intervention in CGL.
  • Management involves lifestyle modification, insulin sensitizers, lipid-lowering therapies, and metreleptin.
  • Comprehensive care and ongoing research into emerging therapies are vital for improving outcomes in CGL.